Status:
UNKNOWN
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN the Treatment of DEPRESSION
Lead Sponsor:
St. Lucas Andreas Ziekenhuis Hospital
Conditions:
Depression
Eligibility:
All Genders
16-65 years
Phase:
PHASE2
Brief Summary
Subjects received rTMS daily on 10 consecutive weekdays (five sessions per week), during 20 minutes per session.During the rTMS session, the coil was centered flat over the right parietal cortex. We ...
Eligibility Criteria
Inclusion
- In and outpatients aged between 16 and 65 who met DSM-IV criteria for major depressive episode, and who had a score of 25 or higher on the 10-item Montgomery Asberg Depression Rating Scale (MADRS) were included
Exclusion
- A history of epilepsy and any other medical disorder that should preclude the administration of rTMS. Only SSRI's, Mirtazapine and Promethazine as psychotropic medication was accepted if the dosage of antidepressive medication had not been changed for 6 weeks, and if the dosage of Promethazine had not been changed for 2 weeks prior to inclusion. Antidepressive medication had to remain stable during the 14 weeks of the study.
- Furthermore: schizophrenic disorder, a piece if metal in the brain, pacemaker and left-handed patients.
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00220610
Start Date
May 1 2004
End Date
December 1 2006
Last Update
September 22 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
st. Lucas Andreas Ziekenhuis/ Hospital
Amsterdam, Netherlands, 1061 AE